Business Description
Treatment com AI Inc
NAICS : 923120
SIC : 8699
ISIN : CA8949421017
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.11 | |||||
Equity-to-Asset | 0.44 | |||||
Debt-to-Equity | 0.46 | |||||
Debt-to-EBITDA | -0.13 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 17.6 | |||||
3-Year EPS without NRI Growth Rate | 30.2 | |||||
3-Year FCF Growth Rate | 45.1 | |||||
3-Year Book Growth Rate | 21.3 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 85.12 | |||||
9-Day RSI | 80.87 | |||||
14-Day RSI | 75.3 | |||||
6-1 Month Momentum % | 0.68 | |||||
12-1 Month Momentum % | -43.62 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.8 | |||||
Quick Ratio | 1.8 | |||||
Cash Ratio | 1.52 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -79.7 | |||||
Shareholder Yield % | -7.25 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -471.6 | |||||
ROIC % | -491.6 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 303.33 | |||||
PB Ratio | 28.44 | |||||
Price-to-Tangible-Book | 30.75 | |||||
EV-to-EBIT | -8.11 | |||||
EV-to-EBITDA | -8.11 | |||||
EV-to-FCF | -22.09 | |||||
Price-to-Net-Current-Asset-Value | 30.75 | |||||
Price-to-Net-Cash | 61.5 | |||||
Earnings Yield (Greenblatt) % | -12.33 | |||||
FCF Yield % | -4.31 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Treatment com AI Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.228 | ||
Beta | -3.67 | ||
Volatility % | 295.85 | ||
14-Day RSI | 75.3 | ||
14-Day ATR (€) | 0.038048 | ||
20-Day SMA (€) | 0.3736 | ||
12-1 Month Momentum % | -43.62 | ||
52-Week Range (€) | 0.0001 - 0.775 | ||
Shares Outstanding (Mil) | 39.24 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Treatment com AI Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Treatment com AI Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Treatment com AI Inc Frequently Asked Questions
What is Treatment com AI Inc(FRA:939)'s stock price today?
When is next earnings date of Treatment com AI Inc(FRA:939)?
Does Treatment com AI Inc(FRA:939) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |